The World Health Organization (WHO) sent international experts to the assess the performance of the VACSERA factories in order for these factories to start manufacturing the vaccine and send it to African countries.
This comes as Health Minister Hala Zayed said Egypt is expected to receive 5 million AstraZeneca coronavirus vaccine doses by the end of this month and another 3 million doses by May.
The new shipment adds to 350,000 Sinopharm doses already imported by Egypt over the recent months, including 300,000 doses also as a gift.
Egypt is to receive 300,000 doses of China’s Sinopharm vaccine as a gift from China to Cairo, later on Monday according to spokesperson of Ministry of Health Khaled Megahed.
Egypt has already received three batches of the vaccine developed by China’s Sinopharm since December, the latest of which was yesterday.
As many as 471 patients were discharged from isolation hospitals after receiving necessary medical care, taking the number of recovered cases to 130,107 so far, the ministry added.
Egypt has approved the emergency use of Chinese sinopharm vaccine and the UK- AstraZeneca vaccine according to Minster of Health Hala Zayed.
Cabinet’s spokesman Nader Saad said Egypt is negotiating with the American Pfizer and the British-Swedish AstraZeneca to obtain batches of coronavirus vaccine.
Egypt’s Health Ministry is working on a strategy to organize the vaccination process for Egyptians which expected to start next week with doctors and Health workers.
Egypt’s head of the scientific committee to combat coronavirus affiliated with the Ministry of Health, Hussam Hosni, said Monday that they will start vaccinating doctors and medical workers starting next week.
The priority in distributing the vaccine will be given to the medical staff in isolation hospitals, as well as chest and fevers hospitals, she said.
The priority will be given to the medical staff, especially those working in isolation hospitals, as well as chest and fevers hospitals.
Health Minister Hala Zayed headed on Monday to Egypt’s Holding Company for Biological Products and Vaccines (VACSERA) to take the second shot of the candidate coronavirus vaccine developed by the Chinese company Sinopharm.